Total Funding
83
66
Total FundingSeed raised
Growth Score
-5 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
32229
Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
- Olof Mollstedt: Founder
- Helen Chen: Co-founder & Co-CEO
About the Company
In its quest to develop new ways to fight cancer, aging, and inflammation, Alixia is engaged in medical research. The company utilizes integrate biology, biophysics, computational chemistry, and clinical inputs to drive new therapeutic innovations. The company's lead compounds focus on lead compounds that disrupt the metabolic and inflammatory
triggers in both cancer and quasi-cancerous cells in the microenvironment.
Women Founded
